Tirzepitide
Novo Nordisk Asks FDA to Block Compounded Versions of Semaglutide
The maker of Ozempic and Wegovy is asking the FDA to step in.
FDA Ruling to Impact Compounded Versions of Popular Weight-Loss Drug
Compound users must now purchase the costly branded version to stay on the drug.
Eli Lilly Cuts Price of Popular Weight-Loss Drug
Patients without insurance coverage have a new option.